Literature DB >> 8123024

Regulation of human insulin receptor RNA splicing in HepG2 cells: effects of glucocorticoid and low glucose concentration.

S Norgren1, L S Li, H Luthman.   

Abstract

Human insulin receptor RNA is expressed in two alternatively spliced forms (Ex. 11- and Ex. 11+) encoding protein isoforms with discrete functional differences. In vivo, the splicing varies between tissues and changes concomitantly with the control of glucose homeostasis. Recently, dexamethasone has been described to increase the relative expression of Ex. 11+ RNA molecules. In this study, we confirm that dexamethasone dose-dependently increases inclusion of exon 11, and demonstrate that low concentrations of glucose decrease inclusion. No effect was observed of either insulin or IGF1. These results suggest that hormonal as well as metabolic factors regulate the splicing of insulin receptor RNA in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123024     DOI: 10.1006/bbrc.1994.1225

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Effect of dexamethasone on insulin receptor mRNA levels, RNA stability and isotype RNA pattern in U-937 human promonocytic cells.

Authors:  M A Leal; P Aller; C Calle
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

2.  Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.

Authors:  Supriya Sen; Indrani Talukdar; Ying Liu; Joseph Tam; Sita Reddy; Nicholas J G Webster
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

3.  SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.

Authors:  Supriya Sen; Indrani Talukdar; Nicholas J G Webster
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

4.  Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension.

Authors:  H Valensise; Y Y Liu; M Federici; D Lauro; D Dell'anna; C Romanini; G Sesti
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

5.  Human Delta1-pyrroline-5-carboxylate synthase: function and regulation.

Authors:  C-A A Hu; S Khalil; S Zhaorigetu; Z Liu; M Tyler; G Wan; D Valle
Journal:  Amino Acids       Date:  2008-04-10       Impact factor: 3.520

6.  Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor.

Authors:  G Sesti; R D'Alfonso; M D Vargas Punti; L Frittitta; V Trischitta; Y Y Liu; P Borboni; R Longhi; A Montemurro; R Lauro
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

7.  Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium.

Authors:  Francisco Westermeier; Carlos Salomón; Marcelo González; Carlos Puebla; Enrique Guzmán-Gutiérrez; Fredi Cifuentes; Andrea Leiva; Paola Casanello; Luis Sobrevia
Journal:  Diabetes       Date:  2011-04-22       Impact factor: 9.461

8.  Assembly of splicing complexes on exon 11 of the human insulin receptor gene does not correlate with splicing efficiency in-vitro.

Authors:  Nicholas J G Webster; Lui-Guojing Evans; Matt Caples; Laura Erker; Shern L Chew
Journal:  BMC Mol Biol       Date:  2004-07-02       Impact factor: 2.946

9.  Aberrant liver insulin receptor isoform a expression normalises with remission of type 2 diabetes after gastric bypass surgery.

Authors:  Vinko Besic; Hongjun Shi; Richard S Stubbs; Mark T Hayes
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

10.  Nova1 is a master regulator of alternative splicing in pancreatic beta cells.

Authors:  Olatz Villate; Jean-Valery Turatsinze; Loriana G Mascali; Fabio A Grieco; Tatiane C Nogueira; Daniel A Cunha; Tarlliza R Nardelli; Michael Sammeth; Vishal A Salunkhe; Jonathan L S Esguerra; Lena Eliasson; Lorella Marselli; Piero Marchetti; Decio L Eizirik
Journal:  Nucleic Acids Res       Date:  2014-09-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.